FDA weighs unknowns of 3-person embryo technique

Published



WASHINGTON (AP) — Genetic experts cautioned the federal government Tuesday that it could take decades to confirm the safety of an experimental fertilization technique that would create babies from the DNA of three people, with the aim of preventing children from inheriting some debilitating diseases.

The Food and Drug Administration heard from supporters and opponents of the provocative technique at a two-day meeting, as the agency considers whether to greenlight testing in women who have defective genes linked to blindness, organ failure and many other inheritable diseases.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.